Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argatroban plus alteplase for acute ischemic stroke
2012-002319-25Phase 2Terminated
- Sponsor
- UTHealth Houston
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of argatroban in ischemic stroke (3 arms), sponsored by UTHealth Houston. Primary endpoint: Excellent functional outcome at day 90. Started Oct 2012; status: terminated.
02
Drugs
argatroban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2012-002319-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002319-25.